Testing a faster way to check lymph nodes in lung cancer surgery
Part of Cancer, Lungs & breathing clinical trials.
This trial compares a new, quick test called OSNA to the standard method for checking lymph nodes in people with early-stage lung cancer who are having robotic surgery. The goal is to see if the new test works as well or better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with non-small cell lung cancer (the most common type of lung cancer).
- Your cancer is at an early stage (stage I or II) and your doctor says it can be removed with surgery.
- Your pre-surgery scans show no signs of cancer in your lymph nodes (called cN0).
- You have not had chemotherapy or immunotherapy before your surgery.
- You do not have another active cancer.
- You agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how well a computer model predicts which lymph nodes need to be removed during lung cancer surgery. If you have early-stage lung cancer that can be removed, you may be eligible.
This study looks at how tumor and blood biomarker results can guide treatment for people with non-small cell lung cancer (NSCLC). Depending on the cancer stage, it may follow standard-of-care treatment plans around surgery or first-line immunotherapy.
This trial is for people with stage IIA to IIIB non-small cell lung cancer that can be removed by surgery. It tests if certain white blood cells (neutrophils) can help predict how well chemotherapy combined with immunotherapy works before surgery.
This trial tests a new robotic ultrasound tool to see if it can better find cancer in lymph nodes during surgery. It may help doctors decide exactly which nodes to remove, avoiding unnecessary surgery.
This trial compares a fast lab test (OSNA) with standard microscope checks to see which better finds cancer in the first lymph node (sentinel node) during surgery for early-stage endometrial cancer. It aims to improve accuracy and speed while avoiding unnecessary lymph node removal.
This study looks at certain lymph nodes removed during surgery for non-small cell lung cancer (NSCLC) that has grown into the covering of the lung. The goal is to better understand lymph node involvement and help guide future treatment decisions.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.